‘Caring for the Carer’: implementing a comprehensive support service model for family caregivers looking after persons with age-related macular degeneration.
Not Applicable
Terminated
- Conditions
- Eye - Diseases / disorders of the eyeAge-related macular degenerationEmotional distressMental Health - Other mental health disorders
- Registration Number
- ACTRN12616001461482
- Lead Sponsor
- niversity of Sydney
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Stopped early
- Sex
- All
- Target Recruitment
- 94
Inclusion Criteria
(a) aged 18 years and over; (b) the primary caregiver to the individual with AMD and related to the care recipient (spouse/partner, child or sibling); and (c) willing to actively engage in at least 10 weekly therapy sessions over a three month period. A primary caregiver will defined as any person who, without being a professional or belonging to a social support network, and in some way, is directly implicated in the patient’s eye care or is directly affected by the patient’s health problem”.
Exclusion Criteria
Caregivers will not be considered for the study if they lack sufficient fluency in spoken English to engage in therapy.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Change in Caregiver Burden Scale (CBS) scores during the 12 month follow-up[12 month follow-up from baseline (i.e. pre-intervention).]
- Secondary Outcome Measures
Name Time Method Change in mental health status among carers, assessed by the Centre for Epidemiologic Studies Depression Scale.[12 month follow-up from baseline (i.e. pre-intervention).];Change in quality of life scores in carers, assessed by the EuroQoL - EQ-5D 5-level scale.[12 month follow-up from baseline (i.e. pre-intervention).];Cost effectiveness of intervention.<br><br>This analysis will be conducted from the perspective of the national health provider in Australia and will determine the cost per person to deliver the support service model and the cost-effectiveness compared with usual care. This will be a within-trial economic evaluation carried out within the time frame and context of the trial. Data on health-related quality of life will be collected during 12-months post-treatment using the EQ-5D-5L questionnaire. EQ-5D scores will be converted into utility values using a valuation algorithm for the Australian population.[12 month follow-up from baseline (i.e. pre-intervention).]